Concepedia

Chris Limberakis

CL

39

Publications

2K

Citations

25

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

University of California, Santa Cruz

Scripps Research Institute

University of California, San Francisco

Foton Motors (China)

Chris Limberakis is an author at Pfizer (United States) specializing in biochemistry, pharmacology, and natural sciences.

Top concepts

BiochemistryMedicinePharmacologyNatural SciencesDrug DiscoveryMedicinal ChemistrySmall MoleculesBioorganic ChemistryBiomolecular EngineeringEngineering

Publications per year

1996–2023

39

Publications

39

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore

J. Richard Miller, Steve Dunham, Igor Mochalkin et al. · Proceedings of the National Academy of Sciences · 2009 · 159 citations · Full text

Drug Target, Bioorganic Chemistry, Antimicrobial Chemotherapy +19

Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules

Cameron R. Pye, William M. Hewitt, Joshua Schwochert et al. · Journal of Medicinal Chemistry · 2017 · 151 citations · Full text

Peptide Engineering, Peptide Science, Chemistry +25

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

David A. Griffith, David J. Edmonds, Jean‐Philippe Fortin et al. · Journal of Medicinal Chemistry · 2022 · 140 citations · Full text

Insulin Signaling, Gastrointestinal Peptide Hormone, Molecular Pharmacology +17

Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance

Arthur C Rand, Siegfried S. F. Leung, Heather Eng et al. · MedChemComm · 2012 · 131 citations

Peptidic macrocyclization via palladium-catalyzed chemoselective indole C-2 arylation

Huijun Dong, Chris Limberakis, Spiros Liras et al. · Chemical Communications · 2012 · 111 citations

Cross-coupling Reaction, Enantioselective Synthesis, Engineering +12

Rows per page

1–5 of 39